Lantibiotics produced by lactic acid bacteria: structure, function and applications

被引:112
作者
Twomey, D
Ross, RP
Ryan, M
Meaney, B
Hill, C [1 ]
机构
[1] Univ Coll Cork, Dept Microbiol, Cork, Ireland
[2] Univ Coll Cork, Natl Food Biotechnol Ctr, Cork, Ireland
[3] TEAGASC, Dairy Prod Res Ctr, Fermoy, Cork, Ireland
来源
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY | 2002年 / 82卷 / 1-4期
关键词
D O I
10.1023/A:1020660321724
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lantibiotics are a diverse group of heavily modified antimicrobial and/or signalling peptides produced by a wide range of bacteria, including a variety of lactic acid bacteria. Based on their diverse structures and mode of action, at least six separate lantibiotic subgroups can be suggested, but all subgroups are characterized by significant post-translational modifications, which include the formation of (beta-methyl)lanthionines, among other unusual alterations. These small peptides are produced, modified, exported, sensed and combated by a complex set of proteins encoded by (usually) co-ordinately regulated operons. In some instances, the production and immunity have been shown to be auto-regulated by the mature lantibiotic. Since their discovery, interest in lantibiotics has been fuelled by their obvious potential as food-grade antimicrobials to improve food safety and quality; a potential which, to date, has been realised only by the longest characterised molecule, nisin. In addition, these peptides are often mooted as alternatives to antibiotics for some biomedical applications. The purpose of this paper is to review recent developments in our understanding of lantibiotic structure, molecular genetics and applications for this unusual class of bacteriocins.
引用
收藏
页码:165 / 185
页数:21
相关论文
共 118 条
[1]   GENE-REGULATION - ACTION OF LEUCINE ZIPPERS [J].
ABEL, T ;
MANIATIS, T .
NATURE, 1989, 341 (6237) :24-25
[2]   GENETIC-ANALYSIS OF EPIDERMIN BIOSYNTHETIC GENES AND EPIDERMIN-NEGATIVE MUTANTS OF STAPHYLOCOCCUS-EPIDERMIDIS [J].
AUGUSTIN, J ;
ROSENSTEIN, R ;
WIELAND, B ;
SCHNEIDER, U ;
SCHNELL, N ;
ENGELKE, G ;
ENTIAN, KD ;
GOTZ, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (03) :1149-1154
[3]  
Benz R, 1991, NISIN NOVEL LANTIBIO, P359
[4]   Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic [J].
Booth, MC ;
Bogie, CP ;
Sahl, HG ;
Siezen, RJ ;
Hatter, KL ;
Gilmore, MS .
MOLECULAR MICROBIOLOGY, 1996, 21 (06) :1175-1184
[5]   Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic [J].
Breukink, E ;
Wiedemann, I ;
van Kraaij, C ;
Kuipers, OP ;
Sahl, HG ;
de Kruijff, B .
SCIENCE, 1999, 286 (5448) :2361-2364
[6]   The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane [J].
Breukink, E ;
vanKraaij, C ;
Demel, RA ;
Siezen, RJ ;
Kuipers, OP ;
deKruijff, B .
BIOCHEMISTRY, 1997, 36 (23) :6968-6976
[7]   MODE OF ACTION OF THE LANTIBIOTIC MERSACIDIN - INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS VIA A NOVEL MECHANISM [J].
BROTZ, H ;
BIERBAUM, G ;
MARKUS, A ;
MOLITOR, E ;
SAHL, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :714-719
[8]   Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics [J].
Brötz, H ;
Josten, M ;
Wiedemann, I ;
Schneider, U ;
Götz, F ;
Bierbaum, G ;
Sahl, HG .
MOLECULAR MICROBIOLOGY, 1998, 30 (02) :317-327
[9]   The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation [J].
Brotz, H ;
Bierbaum, G ;
Reynolds, PE ;
Sahl, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (01) :193-199
[10]   Structure-activity relationships in the peptide antibiotic nisin: Role of dehydroalanine 5 [J].
Chan, WC ;
Dodd, HM ;
Horn, N ;
Maclean, K ;
Lian, LY ;
Bycroft, BW ;
Gasson, MJ ;
Roberts, GCK .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (08) :2966-2969